中国热带医学
中國熱帶醫學
중국열대의학
CHINA TROPICAL MEDICINE
2006年
8期
1340-1344
,共5页
金玉明%Afjal Hossain Khan%Mohammed Alimul Islam%Takeshi Nabeshima%Shingo Inoue%Kouichi Morita
金玉明%Afjal Hossain Khan%Mohammed Alimul Islam%Takeshi Nabeshima%Shingo Inoue%Kouichi Morita
금옥명%Afjal Hossain Khan%Mohammed Alimul Islam%Takeshi Nabeshima%Shingo Inoue%Kouichi Morita
日本脑炎%ML-17减毒活疫苗株%全核苷酸序列测定%突变
日本腦炎%ML-17減毒活疫苗株%全覈苷痠序列測定%突變
일본뇌염%ML-17감독활역묘주%전핵감산서렬측정%돌변
Japanese encephalitis%ML- 17 live attenuated zootic vaccine strain%Nucleotide sequencing%Mutations
目的 鉴别日本脑炎疫苗株ML-17的两个大斑变异株(ML-17L2和ML-17L4)的存在,并通过全基因组序列测定分析引起斑形和毒力改变的基因突变.方法 首先对疫苗株ML-17在传代过程中出现的多斑ML-17sh的两个大斑变异株进行纯化和鉴定,再对两个大斑变异株进行全基因组序列测定和全编码氨基酸序列推导,并与小斑疫苗株ML-17及其大斑亲代野毒株JaOH0566的全核苷酸序列和全编码氨基酸序列进行比较,分析引起斑形改变的基因突变,并应用小白鼠试验检查ML-17变异前后的神经侵袭力和毒力变化. 结果 全基因组序列分析显示两个大斑变异株的核苷酸总数均为10 977个,与ML-17和JaOH0566相比较,分别有33和34个核苷酸变异散在分布于ML-17L2和ML-17L4的全基因组中,其中又分别有12和13个核苷酸导致了氨基酸的改变.在ML-17L2和ML-17L4的衣壳蛋白区没有氨基酸变异,但在包膜蛋白区各有一个氨基酸变异;在5'端非编码区没有核苷酸变异,但在3'端非编码区有3~4个核苷酸变异,且各增加了一个额外的10699核苷酸.ML-17和ML-17sh的小鼠LD50分别为大于1×106FFU和481FFU,变异后毒力明显增强. 结论 发生在两个大斑变异株的第5非结构蛋白区和其它区的氨基酸返祖变异(变回与JaOH0566相同)和新变异,可能引起了斑形的改变;而全部5个氨基酸返祖变异和2~3个氨基酸新变异可能与其毒力改变有关.本次研究为ML-17L2和ML-17L4的斑形和毒力改变提供了分子遗传学基础.
目的 鑒彆日本腦炎疫苗株ML-17的兩箇大斑變異株(ML-17L2和ML-17L4)的存在,併通過全基因組序列測定分析引起斑形和毒力改變的基因突變.方法 首先對疫苗株ML-17在傳代過程中齣現的多斑ML-17sh的兩箇大斑變異株進行純化和鑒定,再對兩箇大斑變異株進行全基因組序列測定和全編碼氨基痠序列推導,併與小斑疫苗株ML-17及其大斑親代野毒株JaOH0566的全覈苷痠序列和全編碼氨基痠序列進行比較,分析引起斑形改變的基因突變,併應用小白鼠試驗檢查ML-17變異前後的神經侵襲力和毒力變化. 結果 全基因組序列分析顯示兩箇大斑變異株的覈苷痠總數均為10 977箇,與ML-17和JaOH0566相比較,分彆有33和34箇覈苷痠變異散在分佈于ML-17L2和ML-17L4的全基因組中,其中又分彆有12和13箇覈苷痠導緻瞭氨基痠的改變.在ML-17L2和ML-17L4的衣殼蛋白區沒有氨基痠變異,但在包膜蛋白區各有一箇氨基痠變異;在5'耑非編碼區沒有覈苷痠變異,但在3'耑非編碼區有3~4箇覈苷痠變異,且各增加瞭一箇額外的10699覈苷痠.ML-17和ML-17sh的小鼠LD50分彆為大于1×106FFU和481FFU,變異後毒力明顯增彊. 結論 髮生在兩箇大斑變異株的第5非結構蛋白區和其它區的氨基痠返祖變異(變迴與JaOH0566相同)和新變異,可能引起瞭斑形的改變;而全部5箇氨基痠返祖變異和2~3箇氨基痠新變異可能與其毒力改變有關.本次研究為ML-17L2和ML-17L4的斑形和毒力改變提供瞭分子遺傳學基礎.
목적 감별일본뇌염역묘주ML-17적량개대반변이주(ML-17L2화ML-17L4)적존재,병통과전기인조서렬측정분석인기반형화독력개변적기인돌변.방법 수선대역묘주ML-17재전대과정중출현적다반ML-17sh적량개대반변이주진행순화화감정,재대량개대반변이주진행전기인조서렬측정화전편마안기산서렬추도,병여소반역묘주ML-17급기대반친대야독주JaOH0566적전핵감산서렬화전편마안기산서렬진행비교,분석인기반형개변적기인돌변,병응용소백서시험검사ML-17변이전후적신경침습력화독력변화. 결과 전기인조서렬분석현시량개대반변이주적핵감산총수균위10 977개,여ML-17화JaOH0566상비교,분별유33화34개핵감산변이산재분포우ML-17L2화ML-17L4적전기인조중,기중우분별유12화13개핵감산도치료안기산적개변.재ML-17L2화ML-17L4적의각단백구몰유안기산변이,단재포막단백구각유일개안기산변이;재5'단비편마구몰유핵감산변이,단재3'단비편마구유3~4개핵감산변이,차각증가료일개액외적10699핵감산.ML-17화ML-17sh적소서LD50분별위대우1×106FFU화481FFU,변이후독력명현증강. 결론 발생재량개대반변이주적제5비결구단백구화기타구적안기산반조변이(변회여JaOH0566상동)화신변이,가능인기료반형적개변;이전부5개안기산반조변이화2~3개안기산신변이가능여기독력개변유관.본차연구위ML-17L2화ML-17L4적반형화독력개변제공료분자유전학기출.
Objective To identify the two large plaque variants (ML-17L2 and ML - 17L4) of vaccine strain ML - 17 and clarify the gene mutations which might cause plaque morphological and virulent changes through the full - length genome sequencing of the 2 ML- 17 variants. Methods The large plaque variants of ML- 17 from ML- 17sh (mixed plaque sizes) were purified and confirmed, the mutations which caused the different plaque morphology through genome sequencing was analized, deducing amino acid (AA) sequence and with attenuated ML- 17(small plaque) and its wild- type strain JaOH0566 (large plaque) wmpared, and the neuroinvasiveness/neurovirulence using animal model was checked. Results The genomic sequence analysis revealed that the 2 virion RNA molecules were 10 977 nucleotides(NT) long, compared with attenuated vaccine strain ML- 17 and its parental wildtype JaOH0566, 33 and 34 NT substitutions were found to be scattered all over the genomes of ML- 17L2 and ML- 17L4, respectively, of these, correspondingly, 12 and 13 resulted in AA changes within viral proteins. No AA mutation was found in C protein region of each variant. But in E protein region, one AA change in each of ML- 17L2 and ML- 17L4. No NT change in the 5' - terminal untranslated regions of the 2 variants. But there were 3 - 4 NT changes in the 3 ' - terminal untranslated regions of the 2 variants, moreover, there was an additional NT change at the same position (NT 10699) of each variant. The mouse LD50 of ML - 17and ML- 17sh were more than 1 × 106 FFU and 481 FFU, respectively. Conclusion All these reverse ( back to JaOH0566) and new mutations in NS5 and other regions of the 2 variants might be resposible for the plaque morphological changes. The virulence of 2 large plaque variants might also be changed, because 5 AA reverse mutations and 2, 3 AA new changes in ML- 17L2, ML-17L4, respectively. These data and comparative results could provide a molecular basis for plaque morphological and virulent changes of ML - 17L2 and Ml - 17L4.